Charalabos‐Markos Dintsios
Impact in
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Environmental Valuation
- Healthcare Policy and Management
- General Health Professions top 5%
- Healthcare cost, quality, practices
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 41
- Pharmaceutical Economics and Policy 17
- Economic and Financial Impacts of Cancer 3
-
- Statistical Methods in Clinical Trials 7
- Co-authors
- Andreas GerberJörg RuofMaarten J. IJzermanMarion DannerJeannette G. van ManenFriedrich Wilhelm SchwartzJ.-Matthias Graf von der SchulenburgAfschin Gandjour
- Journals
- Value in Health (7 papers)The European Journal of Health Economics (4 papers)International Journal of Technology Assessment in Health Care (4 papers)PharmacoEconomics (3 papers)Patient (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Charalabos‐Markos Dintsios
56 papers receiving 740 citations
Peers
Comparison fields: 5 of 106
- Economics and Econometrics 475
- General Health Professions 218
- Statistics and Probability 48
- Pediatrics, Perinatology and Child Health 115
- Geriatrics and Gerontology 18
Countries citing papers authored by Charalabos‐Markos Dintsios
This map shows the geographic impact of Charalabos‐Markos Dintsios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalabos‐Markos Dintsios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalabos‐Markos Dintsios more than expected).
Fields of papers citing papers by Charalabos‐Markos Dintsios
This network shows the impact of papers produced by Charalabos‐Markos Dintsios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalabos‐Markos Dintsios. The network helps show where Charalabos‐Markos Dintsios may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charalabos‐Markos Dintsios, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 4 | |
| 3 | 2020 | 0 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 16 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 3 | |
| 8 | 2018 | 10 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 6 | |
| 11 | 2017 | 10 | |
| 12 | 2015 | 26 | |
| 13 | 2015 | 15 | |
| 14 | 2014 | 12 | |
| 15 | 2012 | 48 | |
| 16 | 2012 | 1 | |
| 17 | 2010 | 7 | |
| 18 | 2009 | 5 | |
| 19 | 2008 | 4 | |
| 20 | The impact of HTA reports on health policy: a systematic review | 2005 | 3 |
About Charalabos‐Markos Dintsios
Charalabos‐Markos Dintsios is a scholar working on Economics and Econometrics, Statistics and Probability, Pediatrics, Perinatology and Child Health, General Decision Sciences and General Health Professions, having authored 62 papers that have together received 768 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (41 papers), Pharmaceutical Economics and Policy (17 papers), Pharmaceutical studies and practices (16 papers), Health and Medical Studies (7 papers), Statistical Methods in Clinical Trials (7 papers), Healthcare cost, quality, practices (5 papers), Clinical practice guidelines implementation (4 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Economics and Econometrics (475 citations), General Health Professions (218 citations), Statistics and Probability (48 citations), Pediatrics, Perinatology and Child Health (115 citations) and Geriatrics and Gerontology (18 citations). Charalabos‐Markos Dintsios has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Andreas Gerber, Jörg Ruof, Maarten J. IJzerman, Marion Danner, Jeannette G. van Manen, Friedrich Wilhelm Schwartz, J.-Matthias Graf von der Schulenburg, Afschin Gandjour, Sigrid Droste and Hilda Bastian. Their work appears in journals such as Value in Health, The European Journal of Health Economics, International Journal of Technology Assessment in Health Care, PharmacoEconomics and Patient.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.